SCOPUS 정보 검색 플랫폼

Volumn 84, Issue 3, 2002, Pages 368-373

Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: Excessive toxicity with a potentially active regimen

(7) González Martín, Antonio a Crespo, Carmen a García López, José Luis a Pedraza, Manuela a Garrido, Pilar a Lastra, Enrique a Moyano, Alfredo a

a HOSPITAL RAMÓN Y CAJAL (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; IFOSFAMIDE; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEUROTOXICITY; NEUTROPENIA; OVARY CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036198668 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6508 Document Type: Article

Times cited : (15)

References (18)

1
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷

2
- 0033902808
- Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer
- (2000) Semin Oncol , vol.27 , Issue.SUPPL. 7 , pp. 4-7
- Ozols, R.F.¹

3
- 0024422604
- Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma. A Gynecologic Oncology Group study
- (1989) J Clin Oncol , vol.7 , pp. 1672-1676
- Sutton, G.P.¹ Blessing, J.A.² Homesley, H.D.³ Berman, M.L.⁴ Malfetano, J.⁵

4
- 0026599140
- Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: Activity in platinum-resistant disease
- (1992) J Clin Oncol , vol.10 , pp. 243-248
- Markman, M.¹ Hakes, T.² Reichman, B.³ Lewis, J.L.⁴ Rubin, S.⁵ Jones, W.⁶ Almadrones, L.⁷ Pizzuto, F.⁸ Hoskins, W.⁹

5
- 0028909291
- A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy
- (1995) Gynecol Oncol , vol.56 , pp. 75-78
- Sorensen, P.¹ Pfeiffer, P.² Bertelsen, K.³

6
- 0024474779
- Navelbine® in advanced ovarian epithelial cancer: A study of the French Oncology Centers
- (1989) Semin Oncol , vol.16 , Issue.SUPPL. 4 , pp. 30-32
- George, M.J.¹ Kerbrat, H.P.² Chauvergne, J.³ Goupil, A.⁴ Lebrun, D.⁵ Guastalla, J.P.⁶ Namer, M.⁷ Bugat, R.⁸ Ayme, Y.⁹ Toussaint, C.¹⁰ Lhomme, C.¹¹

7
- 9544238078
- Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease
- (1996) J Clin Oncol , vol.14 , pp. 2546-2551
- Bajetta, E.¹ Di Leo, A.² Biganzoli, L.³ Mariani, L.⁴ Cappuzzo, F.⁵ Di Bartolomeo, M.⁶ Zilembo, N.⁷ Artale, S.⁸ Magnani, E.⁹ Celio, L.¹⁰ Buzzoni, R.¹¹ Carnaghi, C.¹²

8
- 10344255608
- Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 2993-2999
- Leone, B.A.¹ Vallejo, C.T.² Romero, A.O.³ Perez, J.E.⁴ Cuevas, M.A.⁵ Lacava, J.A.⁶ Sabatini, C.L.⁷ Dominguez, M.E.⁸ Rodriguez, R.⁹ Barbieri, M.R.¹⁰ Ortiz, E.H.¹¹ Salvadori, M.A.¹² Romero Acuña, L.A.¹³ Romero Acuña, J.M.¹⁴ Langhi, M.J.¹⁵ Amato, S.¹⁶ Machiavelli, M.R.¹⁷

9
- 0029827541
- Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer
- (1996) Am J Clin Oncol , vol.19 , pp. 584-588
- Vallejo, C.¹ Romero, A.² Perez, J.³ Cuevas, M.⁴ Lacava, J.⁵ Sabatini, C.⁶ Dominguez, M.⁷ Rodriguez, R.⁸ Barbieri, M.⁹ Romero Acuña, L.¹⁰ Romero Acuña, J.¹¹ Langhi, M.¹² Amato, S.¹³ Salvadori, M.¹⁴ Ortiz, E.¹⁵ Machiavelli, M.¹⁶ Leone, B.¹⁷

10
- 0029995969
- Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: Two phase I studies
- (1996) Semin Oncol , vol.23 , Issue.SUPPL. 6 , pp. 11-15
- Hoffman, P.C.¹ Masters, G.A.² Drinkard, L.C.³ Krauss, S.A.⁴ Samuels, B.L.⁵ Golomb, H.M.⁶ Vokes, E.E.⁷

11
- 0029591692
- Incorporating toxicity considerations into the design of two-stage phase II clinical trials
- (1995) Biometrics , vol.51 , pp. 1372-1383
- Bryant, J.¹ Day, R.²

12
- 0030915166
- Treatment of recurrent ovarian cancer: Increasing options - "Recurent" results
- (1997) J Clin Oncol , vol.15 , pp. 2177-2180
- Ozols, R.F.¹

13
- 0032168461
- A Phase I study of a daily × 3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer
- (1998) Gynecol Oncol , vol.70 , pp. 404-409
- Gershenson, D.M.¹ Burke, T.W.² Morris, M.³ Bast, R.C.⁴ Guaspari, A.⁵ Hohneker, J.⁶ Wharton, J.T.⁷

14
- 0026476151
- The enigma of ifosfamide encephalopathy
- (1992) Anal Oncol , vol.3 , pp. 679-681
- Cerny, T.¹ Küpfer, A.²

15
- 0023902665
- Ifosfamide
- (1988) J Natl Cancer Inst , vol.80 , pp. 556-566
- Zalupski, M.¹ Baker, L.²

16
- 0025951003
- Ifosfamide-induced neurotoxicity
- (1991) Gynecol Oncol , vol.42 , pp. 193-196
- Curtin, J.P.¹ Koonings, P.P.² Gutierrez, M.³ Schlaerth, J.B.⁴ Morrow, C.P.⁵

17
- 0022544458
- Prediction of ifosfamide/mesna associated encephalopathy
- (1986) Eur J Cancer Clin Oncol , vol.22 , pp. 815-819
- Meanwell, C.A.¹ Blake, A.E.² Kelly, K.A.³ Honigsberger, L.⁴ Blackledge, G.⁵

18
- 0025307207
- Ifosfamide and mesna: Response and toxicity at standard and high dose schedules
- (1990) Semin Oncol , vol.17 , Issue.SUPPL. 4 , pp. 68-73
- Antman, K.H.¹ Elias, A.² Ryan, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.